Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3318781)

Published in Appl Environ Microbiol on February 03, 2012

Authors

Jana Junick1, Michael Blaut

Author Affiliations

1: Department of Gastrointestinal Microbiology, German Institute of Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Articles citing this

Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio (2015) 1.18

Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine (2016) 0.99

Timely approaches to identify probiotic species of the genus Lactobacillus. Gut Pathog (2013) 0.95

Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions. Stem Cells Dev (2014) 0.86

High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef Microbes (2016) 0.84

Mutual Cross-Feeding Interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 Explain the Bifidogenic and Butyrogenic Effects of Arabinoxylan Oligosaccharides. Appl Environ Microbiol (2015) 0.83

New molecular quantitative PCR assay for detection of host-specific Bifidobacteriaceae suitable for microbial source tracking. Appl Environ Microbiol (2012) 0.83

The genome of Bifidobacterium pseudocatenulatum IPLA 36007, a human intestinal strain with isoflavone-activation activity. Gut Pathog (2014) 0.81

Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum. Mol Nutr Food Res (2015) 0.80

Qualitative and Semiquantitative Analysis of Fecal Bifidobacterium Species in Centenarians Living in Bama, Guangxi, China. Curr Microbiol (2015) 0.79

Association of germ-free mice with a simplified human intestinal microbiota results in a shortened intestine. Gut Microbes (2014) 0.79

Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria. Urolithiasis (2014) 0.78

Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci U S A (2017) 0.75

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

Clustal W and Clustal X version 2.0. Bioinformatics (2007) 126.47

The phylogeny of prokaryotes. Science (1980) 24.57

Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology (2002) 9.27

GenBank. Nucleic Acids Res (2010) 8.63

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A (2002) 7.21

Protective effect of breast feeding against infection. BMJ (1990) 5.88

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr (2000) 5.84

Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83

Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr (1999) 5.13

Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol (2001) 3.49

Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut (2001) 3.40

Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol (1999) 3.06

Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol (2004) 3.03

The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol (2001) 2.44

Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol (2009) 2.34

16S rRNA and 16S to 23S internal transcribed spacer sequence analyses reveal inter- and intraspecific Bifidobacterium phylogeny. Int J Syst Bacteriol (1996) 2.21

Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A (2010) 2.14

Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol (2005) 1.87

cpnDB: a chaperonin sequence database. Genome Res (2004) 1.83

Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr (2008) 1.78

Identification, detection, and enumeration of human bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol (2002) 1.62

Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis (2004) 1.43

Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J (2009) 1.43

Phylogenetic analysis of the genus Bifidobacterium and related genera based on 16S rDNA sequences. Microbiol Immunol (1998) 1.42

Intestinal flora during the first months of life: new perspectives. Br J Nutr (2002) 1.41

Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy (2003) 1.39

IDT SciTools: a suite for analysis and design of nucleic acid oligomers. Nucleic Acids Res (2008) 1.37

Analysis of bifidobacterial evolution using a multilocus approach. Int J Syst Evol Microbiol (2006) 1.34

New approach to phylogenetic analysis of the genus Bifidobacterium based on partial HSP60 gene sequences. Int J Syst Evol Microbiol (2001) 1.31

Analysis, characterization, and loci of the tuf genes in lactobacillus and bifidobacterium species and their direct application for species identification. Appl Environ Microbiol (2003) 1.28

Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol (2005) 1.27

Characterization of the groEL and groES loci in Bifidobacterium breve UCC 2003: genetic, transcriptional, and phylogenetic analyses. Appl Environ Microbiol (2004) 1.17

Evaluation of using a short region of the recA gene for rapid and sensitive speciation of dominant bifidobacteria in the human large intestine. FEMS Microbiol Lett (1997) 1.17

Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov. Int J Syst Evol Microbiol (2004) 1.17

Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst Appl Microbiol (2003) 1.17

Bifidobacterium lactis DSM 10140: identification of the atp (atpBEFHAGDC) operon and analysis of its genetic structure, characteristics, and phylogeny. Appl Environ Microbiol (2004) 1.14

Classification of a moderately oxygen-tolerant isolate from baby faeces as Bifidobacterium thermophilum. BMC Microbiol (2007) 1.13

Degradation of quercetin and luteolin by Eubacterium ramulus. Appl Environ Microbiol (2001) 1.10

Complete genome sequence of Bifidobacterium animalis subsp. lactis BB-12, a widely consumed probiotic strain. J Bacteriol (2010) 1.09

Gene structure and transcriptional organization of the dnaK operon of Bifidobacterium breve UCC 2003 and application of the operon in bifidobacterial tracing. Appl Environ Microbiol (2005) 1.08

Comparative sequence analysis of the tuf and recA genes and restriction fragment length polymorphism of the internal transcribed spacer region sequences supply additional tools for discriminating Bifidobacterium lactis from Bifidobacterium animalis. Appl Environ Microbiol (2003) 1.07

Species identification of genus Bifidobacterium based on partial HSP60 gene sequences and proposal of Bifidobacterium thermacidophilum subsp. porcinum subsp. nov. Int J Syst Evol Microbiol (2003) 1.07

Bifidobacterium kashiwanohense sp. nov., isolated from healthy infant faeces. Int J Syst Evol Microbiol (2010) 1.05

Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces. Appl Environ Microbiol (2003) 1.03

Complete genome sequence of Bifidobacterium bifidum S17. J Bacteriol (2010) 0.96

Analysis of the genome of the five Bifidobacterium breve strains: plasmid content, pulsed-field gel electrophoresis genome size estimation and rrn loci number. FEMS Microbiol Lett (1993) 0.95

Multiplex PCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. FEMS Microbiol Lett (2003) 0.94

Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR. Lett Appl Microbiol (2004) 0.93

The gene encoding xylulose-5-phosphate/fructose-6-phosphate phosphoketolase (xfp) is conserved among Bifidobacterium species within a more variable region of the genome and both are useful for strain identification. FEMS Microbiol Lett (2005) 0.92

Bifidobacterium stercoris sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2010) 0.82

PCR and real-time PCR primers developed for detection and identification of Bifidobacterium thermophilum in faeces. BMC Microbiol (2008) 0.78

Articles by these authors

Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82

Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis (2014) 2.59

Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation (2006) 2.41

Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17

Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res (2003) 2.07

Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05

Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77

Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One (2013) 1.30

Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr (2003) 1.26

Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2002) 1.22

Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol (2002) 1.17

Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res (2008) 1.14

Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol (2006) 1.13

Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology (2005) 1.11

Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol (2009) 1.11

Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol (2007) 1.10

Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr (2011) 1.09

Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes (2012) 1.08

Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol (2005) 1.06

Modulation of gut mucosal biofilms. Br J Nutr (2005) 1.03

Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol (2008) 1.02

The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ Microbiol (2007) 1.01

Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes (2011) 1.00

Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int J Syst Evol Microbiol (2013) 1.00

Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe (2005) 0.99

Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One (2009) 0.99

Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol (2009) 0.97

Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res (2009) 0.97

Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett (2002) 0.96

Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis (2011) 0.94

Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol (2003) 0.94

Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr (2005) 0.94

Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol (2009) 0.93

Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl Environ Microbiol (2010) 0.92

Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol (2008) 0.92

Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol (2006) 0.90

Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ Microbiol (2008) 0.90

Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos (2009) 0.89

The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem (2008) 0.89

Recent developments and perspectives in the investigation of probiotic effects. Int J Med Microbiol (2009) 0.89

The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr (2009) 0.88

Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol (2013) 0.88

Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme. Appl Environ Microbiol (2004) 0.88

Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr (2011) 0.88

Bioavailability of lignans in human subjects. Nutr Res Rev (2006) 0.86

Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS One (2013) 0.86

Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes (2011) 0.85

The thermal and enzymatic taxifolin-alphitonin rearrangement. J Nat Prod (2011) 0.85

Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond) (2011) 0.84

Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ Microbiol (2010) 0.83

Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res (2010) 0.82

Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol (2010) 0.81

Purification and characterization of an NADH oxidase from Eubacterium ramulus. Arch Microbiol (2002) 0.80

Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation. Glycobiology (2011) 0.80

Marker rescue studies of the transfer of recombinant DNA to Streptococcus gordonii in vitro, in foods and gnotobiotic rats. Appl Environ Microbiol (2003) 0.80

Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications. J Clin Gastroenterol (2010) 0.80

Conversion of dehydrodiferulic acids by human intestinal microbiota. J Agric Food Chem (2009) 0.80

Xanthohumol does not affect the composition of rat intestinal microbiota. Mol Nutr Food Res (2005) 0.80

The growth of the flavonoid-degrading intestinal bacterium, Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiol Ecol (2002) 0.79

Mild gut inflammation modulates the proteome of intestinal Escherichia coli. Environ Microbiol (2013) 0.79

Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst Appl Microbiol (2005) 0.79

Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol (2011) 0.79

Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol Immunother (2013) 0.78

Coffee dietary fiber contents and structural characteristics as influenced by coffee type and technological and brewing procedures. J Agric Food Chem (2007) 0.78

Acetatifactor muris gen. nov., sp. nov., a novel bacterium isolated from the intestine of an obese mouse. Arch Microbiol (2012) 0.78

Degradation of neohesperidin dihydrochalcone by human intestinal bacteria. J Agric Food Chem (2005) 0.78

Impact of nutritional factors on the proteome of intestinal Escherichia coli: induction of OxyR-dependent proteins AhpF and Dps by a lactose-rich diet. Appl Environ Microbiol (2012) 0.78

First bacterial chalcone isomerase isolated from Eubacterium ramulus. Arch Microbiol (2004) 0.78

Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C- and O-glucosides. Appl Environ Microbiol (2012) 0.77

Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis (2006) 0.77

Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br J Nutr (2010) 0.77

Novel insights into E. coli's hexuronate metabolism: KduI facilitates the conversion of galacturonate and glucuronate under osmotic stress conditions. PLoS One (2013) 0.77

Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats. Br J Nutr (2012) 0.76

Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS PharmSciTech (2004) 0.76

A derivatization method for the simultaneous detection of glucosinolates and isothiocyanates in biological samples. Anal Biochem (2013) 0.76

Characterization of high molecular weight coffee fractions and their fermentation by human intestinal microbiota. Mol Nutr Food Res (2009) 0.76

Bioavailability and biotransformation of sulforaphane and erucin metabolites in different biological matrices determined by LC-MS-MS. Anal Bioanal Chem (2015) 0.76

Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter? Inflamm Bowel Dis (2014) 0.75

Ruminococcus luti sp. nov., isolated from a human faecal sample. Syst Appl Microbiol (2002) 0.75

Dietary fiber from coffee beverage: degradation by human fecal microbiota. J Agric Food Chem (2007) 0.75

Characterization and fermentability of an ethanol soluble high molecular weight coffee fraction. J Agric Food Chem (2008) 0.75

Centrifugation of bacterial cells on slide surface improves the spatial distribution, cell recovery and reduces the time of enumeration for fluorescence in situ hybridization. J Microsc (2007) 0.75

The red clover isoflavone irilone is largely resistant to degradation by the human gut microbiota. Mol Nutr Food Res (2010) 0.75